Searchable abstracts of presentations at key conferences in endocrinology

ea0096p9 | Section | UKINETS2023

Evaluating the impact and patient experience of a transition from urine to plasma 5-HIAA measurement

Avani Athauda Dr , Fribbens Dr. Charlotte , Shea Dr. Robyn , Morganstein Dr. Daniel

Background: 5-Hydroxyindoleacetic acid (5-HIAA) is the main metabolite of serotonin and is measured in all patients newly diagnosed with neuroendocrine tumours both to diagnose carcinoid syndrome and to monitor treatment response for those with an elevated baseline level. Each test requires patients to avoid certain foods and collect urine over a 24 hour period. It is not known to what extent patients adhere to these requirements or find them burdensome. There...